Oncology’s Future

Xconomy- Oncology's Future Liquid Biopsies and the Heterogeneity of Cancer

Murali Prahalad, Ph.D., president and CEO of Epic Sciences, recently penned an article for Xconomy looking forward, into oncology's future. The article discusses the intra- and inter- tumor diversity that is often found in cancer patients and what understanding this heterogeneity could  mean for treatment. The article proposes three changes that are needed to understanding of cancer treatment and better the outcome of cancer treatment.


Read the article